Kidney Transplant

happy middle age couple talking to a caregiver

The ideal treatment for patients with end stage renal disease is kidney transplantation because it offers patients an independent life that is free from dialysis. The Rogosin Institute performed New York State’s first living donor kidney transplant in 1963 and its first deceased donor transplant in 1965. The Rogosin Institute’s Immunogenetics and Transplantation Laboratory was the first in the New York Metropolitan Area that made it possible to match organs and allow more people to receive kidney transplants.

“From the first living donor kidney transplant at NYP/Cornell in 1963, Rogosin has pioneered the field of transplantation. Our active participation in kidney exchange for those with incompatible donors has helped propel us to being one of the most active transplant centers in the country. Our approach has always been to make our patients active members of the transplant team.”

–David Serur, MD, Medical Director, Kidney and Pancreas Transplantation, The Rogosin Institute

The Rogosin Institute’s Transplant program is world renowned and is carried out in collaboration with NewYork-Presbyterian/Weill Cornell and provides kidney and pancreas transplantation to both adults and children. Our one year kidney survival rates are excellent at 96%. Transplantation surgery is performed at NewYork-Presbyterian/Weill Cornell, with Rogosin’s transplant nephrologists managing the medical care of transplant patients before and after transplant surgery. Patients are an important part of the transplant team that includes nephrologists, surgeons, immunologists, nurses, pharmacists, technologists, social workers, dietitians and financial counselors.

The Rogosin Institute and NYP/Weill Cornell make every effort to help patients who want and qualify for transplantation, receive a successful kidney transplant. Our goal is to offer improved quality of life to all kidney patients. You must meet certain basic criteria in order to be considered for a potential kidney transplant and be fully evaluated by the transplant team to determine if transplantation is the best treatment option. Transplant coordinators help guide you through the evaluation process.

If transplantation is the best option for you, we work with you to determine the best approach. Patients who have already identified a kidney donor and are considered appropriate for a kidney transplant will work with the coordinator and team to schedule the transplant surgery. If you have identified a potential donor who is incompatible with you, we work with various donor exchange programs affiliated with the transplant program to identify a paired donation. Through the kidney paired exchanges, the Rogosin Institute’s transplant program, in cooperation with NYP/Weill Cornell, has helped facilitate 20% more transplants through kidney paired exchanges. Working with the National Kidney Registry to find and match donors with patients needing a transplant, we participated in the largest exchange ever – 30 transplants – and helped pioneer transplantation of living donor kidneys from coast to coast and improve life expectancy after a kidney transplant.

Click here for additional information about paired living donation.

If you do not have a donor we encourage you to register for a deceased donor transplant at the NYP/Weill Cornell Program in cooperation with The Rogosin Institute.

The Rogosin Institute has been actively involved in the development of immunosuppressive medications, including some of the earliest studies. These are the medications to help prevent rejection of the transplanted organ. Rogosin continues to improve treatments for transplant patients by driving advances in treatment protocols to decrease the need for these medications and to improve our already stellar transplant success rates.

If you are interested in booking an appointment please call 212-746-3099.